Jintropin 120 IU 12iu/vial 10 Vials by Gensci

Usage

1. Remove Jintropin vial from refrigeration 10–15 minutes before use to allow it to reach room temperature and minimize injection discomfort.
2. Inject bacteriostatic water slowly down the inner vial wall using a needle — never directly onto the lyophilized cake — then swirl gently until fully dissolved. Do not shake.
3. Select your timing window before drawing the dose: if running a morning fasted protocol, inject immediately upon waking before any food or caloric beverage; if running pre-sleep, inject 30–60 minutes after your last meal and 30–60 minutes before lying down.
4. Using a U-100 insulin syringe, draw the calculated volume corresponding to your daily IU dose based on your chosen reconstitution concentration.
5. Inject subcutaneously into the abdominal region, rotating sites across the 10-vial cycle to prevent lipohypertrophy at repeated injection points.
6. Log each injection with timestamp, dose, and timing window; cross-reference with IGF-1 test results every four weeks to confirm that the chosen timing protocol is producing the expected physiological response.

Warnings

Frequently asked questions

Why do bodybuilders choose a fasted morning injection window for HGH like Jintropin?

A fasted morning injection capitalizes on minimal circulating insulin, which otherwise competes with GH receptor signaling. When insulin is low, GH receptors on hepatic and muscle tissue are more responsive, leading to a stronger IGF-1 output per IU administered. This makes the morning window particularly efficient for users focused on body-composition changes and metabolic response during daytime training.

Is injecting Jintropin before sleep more effective for muscle recovery than morning dosing?

Pre-sleep dosing is generally more effective for recovery-oriented goals. Exogenous somatropin administered thirty to sixty minutes before sleep extends overnight GH exposure by supplementing — rather than fully replacing — the body's own first-sleep pituitary pulse. This prolonged GH environment supports tissue repair, protein turnover, and lean mass preservation during the overnight fasting period.

How does food intake before a Jintropin injection affect its effectiveness?

Consuming carbohydrates or protein within roughly ninety minutes before injection elevates insulin, which suppresses GH receptor sensitivity and blunts the IGF-1 response. Fat-only meals have a lesser impact. For maximum efficacy, most protocols recommend a minimum two-hour post-meal gap before injecting, or dosing in a fully fasted state, to preserve the insulin-GH reciprocal dynamic.

How do you reconstitute Jintropin 12 IU vials and what syringe should be used?

Add 1–2 mL of bacteriostatic water slowly down the vial wall — never shake, swirl gently until the lyophilized powder dissolves completely. A standard U-100 insulin syringe is the recommended delivery tool for subcutaneous injection. Reconstituting to 1 mL gives 12 IU per mL; reconstituting to 2 mL gives 6 IU per mL, making smaller incremental doses easier to measure accurately.

How should Jintropin vials be stored before and after reconstitution?

Unreconstituted lyophilized vials should be refrigerated at 2–8 °C and kept away from direct light; they remain stable until the printed expiry date under these conditions. Once reconstituted with bacteriostatic water, the solution must be stored in the refrigerator at 2–8 °C and used within 28 days. Never freeze a reconstituted vial, as freezing denatures the protein structure and renders the product inactive. (2) angle_used

Manufacturer

Gensci Pharmaceutical Co., Ltd. is a Chinese biopharmaceutical manufacturer whose Jintropin brand is among the longest-standing commercially produced recombinant somatropin products in the global market, first approved in China in 1997. The company's production facility operates under GMP certification aligned with Chinese National Medical Products Administration (NMPA) standards, supplemented by ISO 9001 quality management system accreditation covering the full manufacturing chain from fermentation to lyophilization. Batch release at Gensci requires HPLC-based purity and identity confirmation as well as LAL limulus amebocyte lysate endotoxin testing — both of which are documented on the accompanying certificate of analysis. Gensci's recombinant expression system produces a 191-amino-acid somatropin molecule that is sequence-identical to pituitary-derived human GH, verified through peptide mapping at the manufacturing stage.